Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old at the time of screening.
- People who are able to understand the study and are willing to give their voluntary consent to participate.
- People who understand French or English.
- For the NAFLD/NASH group: People who have a suspected or confirmed diagnosis of NAFLD or NASH, and who are already scheduled to have a liver biopsy as part of their usual medical care.
- For the non-NAFLD volunteer group: People who do not have a suspected or confirmed diagnosis of NAFLD or NASH.
Who may not be able to join:
- People who are pregnant or trying to become pregnant.
- People whose weight or body size would prevent them from fitting inside the MRI scanning machine.
- People who are unable to understand the study or are unwilling to provide written consent to participate.
- For the non-NAFLD volunteer group: People who have risk factors for developing fat build-up in the liver, including type 2 diabetes, drinking more than 60g of alcohol per day, taking certain medications that can promote fat storage in the liver, or having a body mass index (BMI) above 25 kg/m².
- For the non-NAFLD volunteer group: People who already have fat build-up in the liver, as measured by a specific MRI scan result (confirm with trial site).
- For the NAFLD/NASH group: People who have other causes of long-term liver disease.
- For the NAFLD/NASH group: People who have previously had a liver transplant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: An Tang, MD, MSc, Centre hospitalier de l'Université de Montréal (CHUM)
Phone: 514-890-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fibrosis stage
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.